(Q44622925)

English

Why the findings of published multiple treatment comparison meta-analyses of biologic treatments for rheumatoid arthritis are different: an overview of recurrent methodological shortcomings

scientific article published on 20 October 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Why the findings of published multiple treatment comparison meta-analyses of biologic treatments for rheumatoid arthritis are different: an overview of recurrent methodological shortcomings (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

0 references

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

Kristian Thorlund

1

object named as

Kristian Thorlund

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Edward J. Mills

5

object named as

Edward J Mills

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

author name string

Eric Druyts

2

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

J Antonio Aviña-Zubieta

3

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Ping Wu

4

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

language of work or name

0 references

publication date

20 October 2012

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Annals of the Rheumatic Diseases

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

72

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

1524-1535

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Combination of direct and indirect evidence in mixed treatment comparisons

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-201574

21 January 2018

Evaluation of networks of randomized trials

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-201574

21 January 2018

Indirect comparison of tocilizumab and other biologic agents in patients with rheumatoid arthritis and inadequate response to disease-modifying antirheumatic drugs

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-201574

21 January 2018

The efficacy of inhibiting tumour necrosis factor alpha and interleukin 1 in patients with rheumatoid arthritis: a meta-analysis and adjusted indirect comparisons

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-201574

21 January 2018

A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-201574

21 January 2018

Comparison of certolizumab pegol with other anticytokine agents for treatment of rheumatoid arthritis: a multiple-treatment Bayesian metaanalysis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-201574

21 January 2018

Indirect comparisons of the efficacy of biological antirheumatic agents in rheumatoid arthritis in patients with an inadequate response to conventional disease-modifying antirheumatic drugs or to an anti-tumour necrosis factor agent: a meta-analysis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-201574

21 January 2018

A mixed treatment comparison of the efficacy of anti-TNF agents in rheumatoid arthritis for methotrexate non-responders demonstrates differences between treatments: a Bayesian approach

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-201574

21 January 2018

A mixed treatment comparison of the short-term efficacy of biologic disease modifying anti-rheumatic drugs in established rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-201574

21 January 2018

Abatacept with methotrexate versus other biologic agents in treatment of patients with active rheumatoid arthritis despite methotrexate: a network meta-analysis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-201574

21 January 2018

A dose-response meta-analysis for quantifying relative efficacy of biologics in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-201574

21 January 2018

Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-201574

21 January 2018

Indirect and mixed treatment comparisons in arthritis research

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-201574

21 January 2018

An overview of models used in economic analyses of biologic therapies for arthritis--from current diversity to future consensus

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-201574

21 January 2018

PRISMA statement

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-201574

21 January 2018

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-201574

21 January 2018

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-201574

21 January 2018

Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-201574

21 January 2018

How to use an article reporting a multiple treatment comparison meta-analysis.

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-201574

21 January 2018

Using mixed treatment comparisons and meta-regression to perform indirect comparisons to estimate the efficacy of biologic treatments in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-201574

21 January 2018

Are head-to-head trials of biologics needed? The role of value of information methods in arthritis research

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-201574

21 January 2018

Identifiers

10.1136/ANNRHEUMDIS-2012-201574

1 reference

https://api.fatcat.wiki/v0/release/gchnby4hzzhaxht54s4fkwmdau

30 July 2022

based on heuristic

mapped directly with Wikidata item

release_gchnby4hzzhaxht54s4fkwmdau

1 reference

https://api.fatcat.wiki/v0/release/gchnby4hzzhaxht54s4fkwmdau

30 July 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

https://api.fatcat.wiki/v0/release/gchnby4hzzhaxht54s4fkwmdau

30 July 2022

based on heuristic

mapped directly with Wikidata item

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44622925&oldid=2112972333"